Trusted World of Corona

The Trusted World of Corona (TWOC)

The Trusted World of Corona (TWOC) is a user friendly, trustworthy information platform that is permanently updated with scientific data & information and real world, clinical observations on Corona. The consortium consists of 13 partners, including academic, research institutes and companies (including ICT and Pharma).

The benefits will include better use of treatments, faster development of vaccines and a clearer view on factors that may negatively affect the outcomes of a COVID-19 infection and other future virus outbreaks.

The basis for the research service provided by TWOC is mined data from literature, real world observations (mostly clinical but also self-reporting in COVID-19 apps), and outcomes from intervention trials concerning the worldwide pandemic of COVID-19. Domain experts will review, annotate and filter the information to consolidated information for citizens and for policy makers. The goal of this ‘trusted Hotel concept’ is to assist academic and private researchers, and help the community at large to get near real time accurate, expert-annotated and specific information on COVID-19 in a modern, customised format.

The result of the project will be a trusted, assisted guide (the data Hotel concept) to the world of COVID-19, which helps clinicians, the scientific community, policy makers and politicians and the public at large to get near real time accurate, expert-annotated and specific information in a modern, easily accessible format. Information will be annotated by domain experts. Outcomes will be visualised in the way stakeholders prefer and active assistance is provided in ‘annotation rooms’.

Trusted world of corona

Summary
The goal of this trusted guide to the world of COVID-19 is to help clinicians, the scientific community, policy makers and politicians and the public at large to get near real time accurate, expert-annotated and specific information in a modern, user friendly and easily accessible format. The benefits will include better use of treatments, faster development of vaccines and a clearer view on factors that may negatively affect the outcomes of a COVID-19 infection and other future virus outbreaks.
Technology Readiness Level (TRL)
2 - 6
Time period
36 months
Partners
Leiden UMC
Roche
TNO
Radbound
digi.me
DTACT
DTL
Euretos
Fair Solutions
Frontiers
Human Vaccines Project Europe
LACDR
S&T